Antibiotic optimization via in vitro glycorandomization

@article{Fu2003AntibioticOV,
  title={Antibiotic optimization via in vitro glycorandomization},
  author={Xun Fu and C. Albermann and Jiqing Jiang and Jianchun Liao and Changsheng Zhang and J. Thorson},
  journal={Nature Biotechnology},
  year={2003},
  volume={21},
  pages={1467-1469}
}
In nature, the attachment of sugars to small molecules is often used to mediate targeting, mechanism of action and/or pharmacology. As an alternative to pathway engineering or total synthesis, we report a useful method, in vitro glycorandomization (IVG), to diversify the glycosylation patterns of complex natural products. We have used flexible glycosyltransferases on nucleotide diphosphosugar (NDP-sugar) libraries to generate glycorandomized natural products and then applied chemoselective… Expand
Optimizing Antibiotics 111 Combinatorial chemoenzymatic strategies for in vitro glycoran-domization : Efforts toward antibiotic optimization
The natural product pool, which includes many glycosylated secondary metabolites, is the source of over half of the world’s drug leads. For example, the antibiotics vancomycin and erythromycin, theExpand
Regioselective glycosylation of novobiocin alters activity.
TLDR
Investigation on the antibacterial activity indicate that the presence of galactose moiety helps to improve activity possibly via enhanced cellular uptake, and Koenigs-Knorr and phase transfer glycosylation on novobiocin is investigated. Expand
Recombinant E. coli prototype strains for in vivo glycorandomization.
TLDR
This work reports the construction of several recombinant E. coli prototype strains that allow the facile production of a range of small molecule glycosides and offers vast combinatorial potential by simple fermentation. Expand
Engineering the glycosylation of natural products in actinomycetes.
TLDR
Improvements in this area indicate that glycosyltransferases involved in the biosynthesis of natural products have substrate flexibility regarding the sugar donor but also, less frequently, with respect to the aglycon acceptor, thus enabling an increase in the structural diversity ofnatural products. Expand
Natural product disaccharide engineering through tandem glycosyltransferase catalysis reversibility and neoglycosylation.
A two-step strategy for disaccharide modulation using vancomycin as a model is reported. The strategy relies upon a glycosyltransferase-catalyzed 'reverse' reaction to enable the facile attachment ofExpand
Combining biocatalysis and chemoselective chemistries for glycopeptide antibiotics modification.
TLDR
This work has shown that the expansion of structural diversity in glycopeptide poses substantial barriers to conventional chemical methods for structural modifications, and biochemical approaches have attracted great attention because ample biosynthetic information and sophisticated toolboxes have been made available to change reaction specificity. Expand
The impact of enzyme engineering upon natural product glycodiversification.
TLDR
This review highlights recent progress in the engineering/evolution of enzymes relevant to natural product glycodiversification with a particular focus upon GTs. Expand
Enzymatic methods for glyco(diversification/randomization) of drugs and small molecules.
TLDR
This review covers the influence of Glycosylation upon various drug properties, the classes of glycosyl-conjugating enzymes amenable to glyco(randomization/diversification) schemes, approaches to the synthesis of required substrates and specific examples of glycorandomized libraries utilizing both wild-type and engineered enzymes. Expand
Vancomycin analogues containing monosaccharides exhibit improved antibiotic activity: a combined one-pot enzymatic glycosylation and chemical diversification strategy.
TLDR
A practical one-pot enzymatic approach with regeneration of cosubstrates to synthesize analogues of vancomycin that contain an N-alkyl glucosamine, which exhibited marked improvement in antibiotic activity against a vancomYcin-resistant strain of Enterococcus. Expand
Enhancing the anticancer properties of cardiac glycosides by neoglycorandomization.
TLDR
The glycorandomization of digitoxin leads to analogs that display significantly enhanced potency and tumor specificity and suggests a divergent mechanistic relationship between cardiac glycoside-induced cytotoxicity and Na+/K+-ATPase inhibition. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 15 REFERENCES
Altering the glycosylation pattern of bioactive compounds.
TLDR
Recent advances in this area indicate that antibiotic glycosyltransferases show some substrate flexibility that might allow us to alter the types of sugar transferred to the different aglycons or, less frequently, to change the position of its attachment. Expand
Chemoselective approaches to glycoprotein assembly.
TLDR
Chemoselective approaches for assembling homogeneous glycoconjugates that attempt to reduce the barriers to their synthesis are summarized to make glycconjugate synthesis accessible to a broader community, thereby accelerating progress in glycobiology. Expand
Production of hybrid glycopeptide antibiotics in vitro and in Streptomyces toyocaensis.
TLDR
Cloned glycosyltransferases from glycopeptide antibiotic producers can be used to produce novel hybrid antibiotics, both in vitro and in vivo. Expand
Chemistry, Biology, and Medicine of the Glycopeptide Antibiotics.
The war against infectious bacteria is not over! Although vancomycin and glycopeptide antibiotics have provided a strong last line of defence against many drug-resistant bacteria, their overuse hasExpand
Vancomycin derivatives that inhibit peptidoglycan biosynthesis without binding D-Ala-D-Ala.
TLDR
Results presented here show that carbohydrate-modified vancomycin compounds are effective against resistant bacteria because they interact directly with bacterial proteins involved in the transglycosylation step of cell wall biosynthesis, suggesting new strategies for designing glycopeptide antibiotics that overcome bacterial resistance. Expand
Vancomycin assembly: nature's way.
TLDR
The rules by which nature assembles the glycopeptid (vancomycin) and lipoglycopeptide (teicoplanin) antibiotics are becoming elucidated and verified: first amino acids are synthesized, then joined together and cross-linked. Expand
Tandem action of glycosyltransferases in the maturation of vancomycin and teicoplanin aglycones: novel glycopeptides.
The glycopeptides vancomycin and teicoplanin are clinically important antibiotics. The carbohydrate portions of these molecules affect biological activity, and there is great interest in developingExpand
Incorporation of glucose analogs by GtfE and GtfD from the vancomycin biosynthetic pathway to generate variant glycopeptides.
TLDR
Kinetic analysis indicated the 2, 3, 4, and 6-amino-glucoses were transferred by GtfE with only a 4- to 30-fold drop in k(cat) and no effect on K(m) compared to the native substrate, UDP/TDP-glUCose, suggesting preparative utility. Expand
Solid- and solution-phase synthesis of vancomycin and vancomycin analogues with activity against vancomycin-resistant bacteria.
TLDR
The development of synthetic technology based on the design of a novel selenium safety catch linker, application of this technology to a solid-phase semisynthesis of vancomycin, and the solid- and solution-phase synthesis of van comycin libraries are described. Expand
Bioconjugation by copper(I)-catalyzed azide-alkyne [3 + 2] cycloaddition.
TLDR
The copper-catalyzed cycloaddition reaction between azides and alkynes functions efficiently in aqueous solution in the presence of a tris(triazolyl)amine ligand to make rapid and reliable covalent connections to micromolar concentrations of protein decorated with either of the reactive moieties. Expand
...
1
2
...